Calmodulin-independent, agonistic properties of a peptide containing the calmodulin binding site of estrogen receptor alpha

Mol Cell Endocrinol. 2007 Mar 30;268(1-2):37-49. doi: 10.1016/j.mce.2007.01.012. Epub 2007 Jan 25.

Abstract

Calmodulin (CaM) contributes to estrogen receptor alpha (ER)-mediated transcription. In order to study the underlying mechanisms, we synthesized a peptide including the CaM binding site: ERalpha17p (P(295)-T(311)). This peptide inhibited ER-CaM association, unlike two analogs in which two amino acids required for CaM binding were substituted. Exposure of MCF-7 cells to ERalpha17p down regulated ER, stimulated ER-dependent transcription and enhanced the proliferation of ER-positive breast cancer cell lines. Interestingly, ERalpha17p analogs unable to bind to CaM induced similar responses, demonstrating that ERalpha17p-mediated effects are mainly relevant to mechanisms independent of ER-CaM dissociation. The P(295)-T(311) motif is indeed a platform for multiple post-translational modifications not necessarily CaM-dependent. The additional finding that deletion of the P(295)-T(311) sequence in ER produced a constitutive transcriptional activity revealed that this platform motif has autorepressive functions. With regard to cell function, association of CaM to ER would counteract this autorepression, leading thereby to enhanced ER-mediated transactivation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Binding Sites
  • Calmodulin / antagonists & inhibitors
  • Calmodulin / metabolism*
  • Cell Line, Tumor
  • Down-Regulation
  • Estrogen Receptor alpha / chemistry
  • Estrogen Receptor alpha / metabolism*
  • Humans
  • Molecular Sequence Data
  • Peptides / agonists*
  • Protein Binding
  • Response Elements / genetics
  • Sequence Deletion
  • Transcription, Genetic

Substances

  • Calmodulin
  • Estrogen Receptor alpha
  • Peptides